Works by Sha, Huizi

Results: 19

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer.

Published in:

Advanced Science, 2023, v. 10, n. 1, p. 1, doi. 10.1002/advs.202203298

By:

Liu, Qin;
Chu, Yanhong;
Shao, Jie;
Qian, Hanqing;
Yang, Ju;
Sha, Huizi;
Cen, Lanqi;
Tian, Manman;
Xu, Qiuping;
Chen, Fangjun;
Yang, Yang;
Wang, Weifeng;
Wang, Kai;
Yu, Lixia;
Wei, Jia;
Liu, Baorui

Publication type:

Article

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer (Adv. Sci. 1/2023).

Published in:

Advanced Science, 2023, v. 10, n. 1, p. 1, doi. 10.1002/advs.202370001

By:

Liu, Qin;
Chu, Yanhong;
Shao, Jie;
Qian, Hanqing;
Yang, Ju;
Sha, Huizi;
Cen, Lanqi;
Tian, Manman;
Xu, Qiuping;
Chen, Fangjun;
Yang, Yang;
Wang, Weifeng;
Wang, Kai;
Yu, Lixia;
Wei, Jia;
Liu, Baorui

Publication type:

Article

Enhancement of radiotherapeutic efficacy for esophageal cancer by paclitaxel-loaded red blood cell membrane nanoparticles modified by the recombinant protein anti-EGFR-iRGD.

Published in:

Journal of Biomaterials Applications, 2018, v. 33, n. 5, p. 707, doi. 10.1177/0885328218809019

By:

Ren, Wei;
Sha, Huizi;
Yan, Jing;
Wu, Puyuan;
Yang, Ju;
Li, Rutian;
Zhang, Hang;
Yu, Lixia;
Qian, Hanqing;
Liu, Baorui

Publication type:

Article

Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1015232

By:

Juan Du;
Linxi Zhu;
Huizi Sha;
Zhengyun Zou;
Jie Shen;
Weiwei Kong;
Lianjun Zhao;
Qing Gu;
Lixia Yu;
Yudong Qiu;
Baorui Liu

Publication type:

Article

Tumor-penetrating peptide fused EGFR single-domain antibody enhances radiation responses following EGFR inhibition in gastric cancer.

Published in:

Oncology Reports, 2021, v. 45, n. 1, p. 404

By:

Ji, Fuzhi;
Sha, Huizi;
Meng, Fanyan;
Zhu, Anqing;
Ding, Naiqing;
Zhang, Hang;
Xu, Hui;
Qian, Hanqing;
Yu, Lixia;
Liu, Qizhan;
Liu, Baorui

Publication type:

Article

Tumor-penetrating peptide fused EGFR single-domain antibody enhances radiation responses following EGFR inhibition in gastric cancer.

Published in:

Oncology Reports, 2018, v. 40, n. 3, p. 1583, doi. 10.3892/or.2018.6532

By:

Ji, Fuzhi;
Sha, Huizi;
Meng, Fanyan;
Zhu, Anqing;
Ding, Naiqing;
Zhang, Hang;
Xu, Hui;
Qian, Hanqing;
Yu, Lixia;
Liu, Qizhan;
Liu, Baorui

Publication type:

Article

Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.

Published in:

Oncology Reports, 2017, v. 37, n. 4, p. 2063, doi. 10.3892/or.2017.5440

By:

YING HUANG;
XIHAN LI;
HUIZI SHA;
LIANRU ZHANG;
XINYU BIAN;
XIAO HAN;
BAORUI LIU

Publication type:

Article

Coupling Gd-DTPA with a bispecific, recombinant protein anti-EGFR-iRGD complex improves tumor targeting in MRI.

Published in:

Oncology Reports, 2016, v. 35, n. 6, p. 3227, doi. 10.3892/or.2016.4712

By:

XIAOYAN XIN;
HUIZI SHA;
JINGTAO SHEN;
BING ZHANG;
BIN ZHU;
BAORUI LIU

Publication type:

Article

First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial.

Published in:

Signal Transduction & Targeted Therapy, 2024, p. 1, doi. 10.1038/s41392-024-01857-6

By:

Sha, Huizi;
Tong, Fan;
Ni, Jiayao;
Sun, Yi;
Zhu, Yahui;
Qi, Liang;
Li, Xiaoqin;
Li, Wei;
Yang, Yan;
Gu, Qing;
Zhang, Xing;
Wang, Xiaoxuan;
Zhu, Chan;
Chen, Dongsheng;
Liu, Baorui;
Du, Juan

Publication type:

Article

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer.

Published in:

Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-09296-6

By:

Ding, Naiqing;
Zou, Zhengyun;
Sha, Huizi;
Su, Shu;
Qian, Hanqing;
Meng, Fanyan;
Chen, Fangjun;
Du, Shiyao;
Zhou, Shujuan;
Chen, Hong;
Zhang, Lianru;
Yang, Ju;
Wei, Jia;
Liu, Baorui

Publication type:

Article

Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein.

Published in:

International Journal of Nanomedicine, 2018, v. 13, p. 5347, doi. 10.2147/IJN.S165109

By:

Chen, Hong;
Sha, Huizi;
Zhang, Lianru;
Qian, Hanqing;
Chen, Fangjun;
Ding, Naiqing;
Ji, Liulian;
Zhu, Anqing;
Xu, Qiuping;
Meng, Fanyan;
Yu, Lixia;
Zhou, Yan;
Liu, Baorui

Publication type:

Article

Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.

Published in:

International Journal of Nanomedicine, 2018, v. 13, p. 4961, doi. 10.2147/IJN.S170148

By:

Zhang, Zhen;
Qian, Hanqing;
Huang, Jie;
Sha, Huizi;
Zhang, Hang;
Yu, Lixia;
Liu, Baorui;
Hua, Dong;
Qian, Xiaoping

Publication type:

Article

Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients.

Published in:

Scientific Reports, 2017, p. 40272, doi. 10.1038/srep40272

By:

Su, Shu;
Hu, Bian;
Shao, Jie;
Shen, Bin;
Du, Juan;
Du, Yinan;
Zhou, Jiankui;
Yu, Lixia;
Zhang, Lianru;
Chen, Fangjun;
Sha, Huizi;
Cheng, Lei;
Meng, Fanyan;
Zou, Zhengyun;
Huang, Xingxu;
Liu, Baorui

Publication type:

Article

CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients.

Published in:

Scientific Reports, 2016, p. 20070, doi. 10.1038/srep20070

By:

Su, Shu;
Hu, Bian;
Shao, Jie;
Shen, Bin;
Du, Juan;
Du, Yinan;
Zhou, Jiankui;
Yu, Lixia;
Zhang, Lianru;
Chen, Fangjun;
Sha, Huizi;
Cheng, Lei;
Meng, Fanyan;
Zou, Zhengyun;
Huang, Xingxu;
Liu, Baorui

Publication type:

Article

Efficacy and safety of secondline therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1210859

By:

Xin Qiu;
Changchang Lu;
Huizi Sha;
Yahui Zhu;
Weiwei Kong;
Fan Tong;
Qiaoli Wang;
Fanyan Meng;
Baorui Liu;
Juan Du

Publication type:

Article

Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency.

Published in:

OncoTargets & Therapy, 2016, v. 9, p. 3153, doi. 10.2147/OTT.S100678

By:

Xinyu Bian;
Puyuan Wu;
Huizi Sha;
Hanqing Qian;
Qing Wang;
Lei Cheng;
Yang Yang;
Mi Yang;
Baorui Liu

Publication type:

Article

Recent Progress on Therapeutic Vaccines for Breast Cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.905832

By:

Zhang, Lianru;
Zhou, Xipeng;
Sha, Huizi;
Xie, Li;
Liu, Baorui

Publication type:

Article

Case Report: Pathological Complete Response in a Lung Metastasis of Phyllodes Tumor Patient Following Treatment Containing Peptide Neoantigen Nano-Vaccine.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.800484

By:

Sha, Huizi;
Liu, Qin;
Xie, Li;
Shao, Jie;
Yu, Lixia;
Cen, Lanqi;
Li, Lin;
Liu, Fangcen;
Qian, Hanqing;
Wei, Jia;
Liu, Baorui

Publication type:

Article

AGIG Chemo-Immunotherapy in Patients With Advanced Pancreatic Cancer: A Single-Arm, Single-Center, Phase 2 Study.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.693386

By:

Dai, Wangshu;
Qiu, Xin;
Lu, Changchang;
Zou, Zhengyun;
Sha, Huizi;
Kong, Weiwei;
Liu, Baorui;
Du, Juan

Publication type:

Article